In melanoma, Dac51 enhances m6A modification levels in JunB and C/EBPβ mRNA by inhibiting FTO, which facilitates the binding of YTHDF2 to both mRNAs, leading to significant reductions in JunB and C/EBPβ expression. Here, JUNB is linked to melanoma.